IDEC-CE9: IDPH and partner SmithKline Beecham began a Phase I/II trial

IDEC Pharmaceuticals Corp. (IDPH) Product: IDEC-CE9.1, Primatized antibody directed at CD4 Indication: Rheumatoid arthritis Status: IDPH and partner SmithKline Beecham began a Phase I/II trial in 45 ...